Strovite One Tablet
NDC Package 0642-0207-03
Package Information
Strovite One (vitamin a, calcium pantothenate, ascorbic acid, cholecalciferol, .alpha.-tocopherol succinate, d-, thiamine, riboflavin, niacinamide, pyridoxine hydrochloride, folic acid, biotin, cyanocobalamin, selenium, magnesium oxide, zinc oxide, cupric sulfate, manganese, chromium, .alpha.-lipoic acid, and lutein) tablets is a medication a multivitamin product used to treat or prevent vitamin deficiency due to poor diet, certain illnesses, or during pregnancy. This formulation utilizes a tablet delivery system. Marketed by Exeltis Usa, Inc., this product is identified by NDC 0642-0207.
Identification & Billing
Clinical Specifications
- MANGANESE 45 ug/1
- VITAMIN A 15 mg/1
- CALCIUM PANTOTHENATE 300 mg/1
- ASCORBIC ACID 100 ug/1
- CHOLECALCIFEROL 7.5 mg/1
- .ALPHA.-TOCOPHEROL SUCCINATE, D- 25 ug/1
- THIAMINE 50 ug/1
- RIBOFLAVIN 1.5 mg/1
- NIACINAMIDE 50 ug/1
- PYRIDOXINE HYDROCHLORIDE 1700 ug/1
- FOLIC ACID 5 mg/1
- BIOTIN 50 mg/1
- CYANOCOBALAMIN 1.5 mg/1
- SELENIUM 25 mg/1
- MAGNESIUM OXIDE 25 mg/1
- ZINC OXIDE 5 mg/1
- CUPRIC SULFATE 100 ug/1
- CHROMIUM 20 mg/1
- ALPHA LIPOIC ACID 900 ug/1
- LUTEIN 25 mg/1
- Allergens - [CS]
- Analogs/Derivatives - [Chemical/Ingredient]
- Ascorbic Acid - [CS]
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Standardized Chemical Allergen - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
- Vitamin A - [CS]
- Vitamin A - [EPC] (Established Pharmacologic Class)
- Vitamin B 12 - [CS]
- Vitamin B 6 - [Chemical/Ingredient]
- Vitamin B12 - [EPC] (Established Pharmacologic Class)
- Vitamin B6 Analog - [EPC] (Established Pharmacologic Class)
- Vitamin C - [EPC] (Established Pharmacologic Class)
- Vitamin D - [CS]
- Vitamin D - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 0642 - Exeltis Usa, Inc.
- 0642-0207 - Strovite One
- 0642-0207-03 - 1 BLISTER PACK in 1 BOX / 3 TABLET in 1 BLISTER PACK
- 0642-0207 - Strovite One
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0642-0207). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0642-0207-03 identifies a specific commercial package of 1 blister pack in 1 box / 3 tablet in 1 blister pack of Strovite One Caplets, a human prescription drug labeled by Exeltis Usa, Inc.. This tablet is formulated for oral use and contains manganese; vitamin a; calcium pantothenate; ascorbic acid; cholecalciferol; .alpha.-tocopherol succinate, d-; thiamine; riboflavin; niacinamide; pyridoxine hydrochloride; folic acid; biotin; cyanocobalamin; selenium; magnesium oxide; zinc oxide; cupric sulfate; chromium; alpha lipoic acid; lutein as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Exeltis Usa, Inc. on May 04, 2001. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is a multivitamin product used to treat or prevent vitamin deficiency due to poor diet, certain illnesses, or during pregnancy. Vitamins are important building blocks of the body and help keep you in good health.
How is this Exeltis Usa, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00642020703. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.